BVT Aktienanleihe MRK 31.12.2024/ DE000VM7BUA9 /
2024-04-30 8:02:28 PM | Chg.-0.290 | Bid9:59:49 PM | Ask9:59:54 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
99.080EUR | -0.29% | - Bid Size: - |
- Ask Size: - |
MERCK KGAA O.N. | 155.00 EUR | 2024-12-31 | Call |
GlobeNewswire
05-01
HiberCell Announces First Patient Dosed in Clinical Collaboration with Merck, Evaluating HC-7366 in ...
GlobeNewswire
05-01
Global Impact, on behalf of the Advancing Health Online Initiative (AHO) and Gavi, The Vaccine Allia...
GlobeNewswire
05-01
G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA